
    
      This is an open-label, multi-center, randomized concurrent-control study with the treatment
      duration of 90 days. Subjects will be recruited into the study based upon the inclusion and
      exclusion criteria provided. Eligible subjects will be examined for baseline evaluation and
      lens fitting. Up to sixty (60) subjects will wear the test contact lenses for daily wear and
      up to twenty-eight (28) subjects will wear the control contact lenses. The subjects will
      attend seven scheduled study visits and will undergo standard ophthalmic evaluation for
      contact lens care. The subjects will be followed for a period of three months (90 days)
      following dispensing of the Test and Control Device.
    
  